Editorial: Dopa decarboxylase inhibitors.
出版信息
Br Med J. 1974 Nov 2;4(5939):250-1. doi: 10.1136/bmj.4.5939.250.
Abstract
摘要
相似文献
1
Editorial: Dopa decarboxylase inhibitors.社论：多巴脱羧酶抑制剂
Br Med J. 1974 Nov 2;4(5939):250-1. doi: 10.1136/bmj.4.5939.250.
2
Sinemet and the treatment of Parkinsonism.息宁与帕金森症的治疗
Ann Intern Med. 1981 Mar;94(3):364-70. doi: 10.7326/0003-4819-94-3-364.
3
Levodopa alone and in combination with a peripheral decarboxylase inhibitor benserazide (Madopar) in the treatment of Parkinson's disease: A controlled clinical trial.左旋多巴单独及与外周脱羧酶抑制剂苄丝肼（美多芭）联合用于帕金森病治疗：一项对照临床试验。
J Neurol. 1975 Dec 2;211(1):1-9. doi: 10.1007/BF00312459.
4
[L-dopa-decarboxylase inhibitor combination preparation (Sinemet) in parkinsonism and syndromes imitating parkinsonism. 1 year's experience with 34 patients].[左旋多巴-脱羧酶抑制剂复方制剂（信尼麦）治疗帕金森病及类帕金森综合征。34例患者1年的经验]
Tidsskr Nor Laegeforen. 1976 Feb 10;96(4):225, 234-6.
5
[L-dopa with extracerebral dope-decarboxylase inhibitor (MK-486) in the treatment of Parkinson's disease. Preliminary evaluation of results].[左旋多巴与脑外多巴脱羧酶抑制剂（MK - 486）治疗帕金森病。结果的初步评估]
Neurol Neurochir Pol. 1976 May-Jun;10(3):345-52.
6
[Levodopa and decarboxylase inhibitors in Parkinson's disease].[左旋多巴与脱羧酶抑制剂治疗帕金森病]
Lakartidningen. 1977 Jan 5;74(1-2):37-40.
7
8
[L-dopa therapy for Parkinsonism and its relationship to surgical methods of treatments].[左旋多巴治疗帕金森病及其与手术治疗方法的关系]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1974;74(5):701-6.
9
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.左旋多巴联合卡比多巴治疗帕金森病患者与单用左旋多巴治疗的一年对比。
Lancet. 1973 Dec 29;2(7844):1459-62. doi: 10.1016/s0140-6736(73)92729-3.
10
[Aspects of long-term treatment with levodopa alone and levodopa combined with dopa decarboxylase inhibitors].[左旋多巴单独治疗及左旋多巴与多巴脱羧酶抑制剂联合治疗的长期治疗方面]
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Neurol Psihiatr Neurochir. 1982 Oct-Dec;27(4):261-70.
引用本文的文献
1
Green Multi-Platform Solution for the Quantification of Levodopa Enantiomeric Excess in Solid-State Mixtures for Pharmacological Formulations.用于药物制剂固态混合物中左旋多巴对映体过量定量分析的绿色多平台解决方案。
Molecules. 2021 Aug 15;26(16):4944. doi: 10.3390/molecules26164944.
本文引用的文献
1
A method for the determination of some amino acid decarboxylases.一种测定某些氨基酸脱羧酶的方法。
J Biol Chem. 1960 Jan;235:124-7.
2
Dopa decarboxylase: substrates, coenzyme, inhibitors.多巴脱羧酶：底物、辅酶、抑制剂。
Pharmacol Rev. 1966 Mar;18(1):53-60.
3
Pyridoxine reversal of L-dopa effects in Parkinsonism.帕金森病中吡哆醇对左旋多巴作用的逆转
Trans Am Neurol Assoc. 1969;94:81-4.
4
Metabolism and absorption of L-3,4 dihydroxyphenylalanine in patients with Parkinson's disease.帕金森病患者中L-3,4-二羟基苯丙氨酸的代谢与吸收
Ann N Y Acad Sci. 1971 Jul 6;179:126-40. doi: 10.1111/j.1749-6632.1971.tb46895.x.
5
Methyldopahydrazine as an adjunct to L-dopa therapy in parkinsonism.甲基多巴肼作为左旋多巴治疗帕金森病的辅助药物。
Neurology. 1972 Apr;22(4):384-92. doi: 10.1212/wnl.22.4.384.
6
Levodopa, carbidopa, and pyridoxine in Parkinson disease. Metabolic interactions.左旋多巴、卡比多巴和吡哆醇在帕金森病中的代谢相互作用
Arch Neurol. 1974 Jun;30(6):444-7. doi: 10.1001/archneur.1974.00490360020005.
7
Modification of Parkinsonism--chronic treatment with L-dopa.帕金森病的改善——左旋多巴的长期治疗
N Engl J Med. 1969 Feb 13;280(7):337-45. doi: 10.1056/NEJM196902132800701.
8
A year's comparison of treatment of patients with parkinson's disease with levodopa combined with carbidopa versus treatment with levodopa alone.左旋多巴联合卡比多巴治疗帕金森病患者与单用左旋多巴治疗的一年对比。
Lancet. 1973 Dec 29;2(7844):1459-62. doi: 10.1016/s0140-6736(73)92729-3.
Zotero 插件